| Charles Allen Gorske, RPH | |
|
485 N Rolling Meadows Dr, Fond Du Lac, WI 54937-9784 | |
| (920) 921-6759 | |
| (920) 921-6759 |
| Full Name | Charles Allen Gorske |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 485 N Rolling Meadows Dr, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003101668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | R-6566 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Allen Gorske, RPH 134 Fanna St, Fond Du Lac, WI 54935-5816 Ph: (920) 922-7715 | Charles Allen Gorske, RPH 485 N Rolling Meadows Dr, Fond Du Lac, WI 54937-9784 Ph: (920) 921-6759 |
News Archive
Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new molecular drivers of Parkinson's disease using a sophisticated statistical technique called multiscale gene network analysis.
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.
Synosia Therapeutics today announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson's patients, has a good safety profile and is well tolerated. Results from an open-label, proof-of-mechanism study of SYN-118 (CL02) were presented at the World Parkinson Congress in Glasgow, Scotland.
A new study found one in five nursing home residents with advanced dementia harbor strains of drug-resistant bacteria and more than 10 percent of the drug-resistant bacteria are resistant to four or more antibiotic classes. The research was published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Addenbrooke's Hospital in Cambridge along with 20 other hospitals from across the world and healthcare technology leader, NVIDIA, have used artificial intelligence (AI) to predict Covid patients' oxygen needs on a global scale.
› Verified 2 days ago
Mrs. Michelle M Cunningham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 192 N Main St, Walgreens Pharmacy, Fond Du Lac, WI 54935 Phone: 920-922-9634 Fax: 920-921-2760 | |
John M Driedric, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 616 W Johnson St, Fond Du Lac, WI 54935 Phone: 920-921-5490 | |
Maris Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 420 E Division St, Pharmacy Plus, Fond Du Lac, WI 54935 Phone: 920-926-8585 Fax: 920-926-8935 | |
Rhett R Koski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 W Pioneer Rd, Fond Du Lac, WI 54935 Phone: 920-907-0556 Fax: 920-907-0639 | |
Tou Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1060 E Johnson St, Fond Du Lac, WI 54935 Phone: 920-266-4323 | |
Ms. Lori Sue Pachefsky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 192 N Main St, Fond Du Lac, WI 54935 Phone: 920-921-5264 Fax: 920-921-2760 |